The drug industry’s legal fight against Missouri’s 340B contract pharmacy access law was dealt another blow yesterday after a federal [...] …
Category: News Alert
News Alert
Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference
Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge yesterday rejected Swiss pharmaceutical company Novartis’ bid to block Missouri’s law prohibiting drugmaker 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The North Dakota House and the South Dakota Senate have each overwhelmingly voted to pass bills that would prohibit drugmakers [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Kentucky Senate late yesterday overwhelmingly voted to pass a bill prohibiting drugmaker 340B contract pharmacy restrictions in the state—the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Tom Engels, who served as Health Resources and Services Administration (HRSA) administrator during the last two years of President Donald [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Robert F. Kennedy Jr., President Donald Trump’s pick to lead the U.S. Department of Health and Human Services (HHS), fielded [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novartis this week became the fifth manufacturer to sue the Health Resources and Services Administration (HRSA) to implement a 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge this week denied AstraZeneca’s request for a preliminary injunction against Mississippi’s contract pharmacy access law, marking the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
U.S. Rep. Earl “Buddy” Carter (R-Ga.), a pharmacist who has advocated for major changes to the 340B program which many [...] …